Zainab Shinkafi-Bagudu Assumes the Role of UICC President
After the Applause: Six ESMO Trials that Changed Cancer Treatment
Meet the International Panelists at OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition
Ramy Sedhom: Time Is Money, but for Whom?
11 Colorectal Cancer Trials to Watch at ESMO 2026
UICC Announces New Board of Directors for 2026–2028
ESMO 2026 Guideline: Key Updates in Gastric and Esophageal Cancer Management
Machine Learning Improves AML Relapse Risk Prediction Beyond ELN 2022: HARMONY Study
Hematology (OncoDaily Blood) is OncoDaily’s dedicated platform for hematologic oncology, covering the latest research, clinical advances and expert perspectives. Its coverage spans the major hematologic malignancies: acute and chronic leukemias, Hodgkin and non-Hodgkin lymphomas, multiple myeloma and other plasma cell disorders, myelodysplastic and myeloproliferative neoplasms. OncoDaily Blood follows advances in the understanding, diagnosis and treatment of blood cancers, with a focus on emerging strategies, targeted therapies, immunotherapies, CAR-T cell therapy, hematopoietic stem cell transplantation, and molecular and measurable residual disease testing. It reports on practice-changing clinical trials, major hematology congresses, treatment guidelines, regulatory approvals and real-world evidence.
